Reich O, Seitz M, Gratzke C, Schlenker B, Bachmann A, Stief C
Urologische Klinik und Poliklinik, Klinikum Grosshadern, Ludwig-Maximilians-Universität, 81377 , München,
Urologe A. 2006 Jun;45(6):769-80; quiz 781-2. doi: 10.1007/s00120-006-1039-1.
Today, the surgical treatment of the benign prostatic syndrome (BPS) often follows a course of drug treatment. Besides conventional transurethral resection of the prostate (TURP), which has represented the standard therapeutic option for decades, and its in part significant modifications ("vaporizing resection"; bipolar resection), much of the interest has shifted to alternative instrumental procedures like transurethral microwave therapy (TUMT), transurethral needle ablation of the prostate (TUNA) or several laser techniques. By reviewing the current literature, preferably from randomized controlled trials, these different procedures are critically assessed. Moreover, the present role of open prostatectomy is discussed.
如今，良性前列腺综合征（BPS）的外科治疗通常在药物治疗之后进行。除了代表了数十年标准治疗选择的传统经尿道前列腺切除术（TURP）及其部分重大改良术式（“汽化切除术”；双极切除术）之外，人们的兴趣已很大程度上转向了诸如经尿道微波热疗（TUMT）、经尿道前列腺针刺消融术（TUNA）或几种激光技术等替代性器械操作。通过回顾当前文献，最好是来自随机对照试验的文献，对这些不同的操作进行了批判性评估。此外，还讨论了开放性前列腺切除术目前的作用。
